Under Pressure…Medicating and Mitigating Dry Eye and Glaucoma

0.75 CME
0.75 ABO MOC
45 MINS
$0 FEE
SAVE
Under Pressure…Medicating and Mitigating Dry Eye and Glaucoma

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education


Support Statement

This activity is supported by an educational grant from Allergan, Inc.


Activity Description

It is estimated that 16.4 million Americans have been diagnosed with dry eye disease (DED), with an estimated 6 million additional cases that have not been formally diagnosed. A recent study has also demonstrated a high incidence of DED in patients with newly diagnosed primary open-angle glaucoma. Furthermore, some medications used for the treatment of glaucoma have been demonstrated to cause or exacerbate DED. In this CME activity, experts in the field will assess the utility of current and emerging therapeutic options for the treatment of DED in patients with glaucoma as well as discuss new medications and minimally invasive glaucoma surgery techniques and procedures that can improve outcomes in patients with glaucoma and ocular surface disorders.


Target Audience

The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with dry eye and glaucoma.


Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Assess the utility of current and emerging therapeutic options for the treatment of dry eye in patients with glaucoma.
  • Describe new medications, as well as minimally invasive glaucoma surgery (MIGS) techniques and procedures that can improve outcomes in patients with glaucoma and ocular surface disorders.

Activity Chair

Terry Kim, MD
Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea and External Disease Division
Director, Refractive Surgery Service
Vice-President/President-Elect, American Society of Cataract and Refractive Surgery (ASCRS)
Duke University Eye Center
Durham, NC


Faculty

Lisa M. Nijm, MD, JD
Warrenville EyeCare and LASIK
Founder and Medical Director
Cornea, Cataract, and Refractive Surgery
Assistant Clinical Professor of Ophthalmology
University of Illinois Eye and Ear Infirmary
Department of Ophthalmology and Visual Science
Chicago, IL

Thomas W. Samuelson, MD
Attending Surgeon
Glaucoma and Anterior Segment Surgery
Minnesota Eye Consultants, P.A.
Adjunct Professor of Ophthalmology
University of Minnesota
Minneapolis, MN


Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABOSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning requirements for the American Board of Ophthalmology’s Maintenance of Certification (ABO MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting MOC credit.

Upon successful completion, learners who opt-in by providing their ABO ID and DOB (MM/DD) will earn MOC credits equivalent to the amount of CME credits claimed for the activity. The CME activity provider will submit learner completion information to the ACCME for the purpose of granting ABO MOC credits within 30 days of activity completion.

This enduring material is approved for 1 year from the date of original release, October 30, 2020, through October 29, 2021.


How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 of 5 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.

Activity Chair and Faculty report the following relationship(s)

Terry Kim, MD
Consulting Fee: Aerie, Alcon, Allergan, Avedro, Avellino Labs, Bausch + Lomb, BlephEx, Cornea Gen, Dompé, Eyenovia, J&J Vision, Kala, NovaBay, Novartis, Ocular Therapeutix, Omeros, Presbyopia Therapies, Shire, Sight Sciences, Simple Contacts, Surface, Zeiss
Ownership Interest: Avellino Labs, CorneaGen, Eyenovia, Kala, NovaBay Pharmaceuticals, Ocular Therapeutix, Omeros, Simple Contacts

Lisa M. Nijm, MD, JD
Consulting Fee: Akorn, Alcon, Allergan, Bruder, EyePoint, J&J Vision, Kala, Novartis, Ocular Therapeutix, Omeros, Sun, Zeiss
Speakers Bureau: Kala, Novartis, Omeros, Sun

Thomas W. Samuelson, MD
Consulting Fee: Aerie, Alcon, Allergan, Bausch + Lomb/Valeant, BELKIN Laser, ELT Sight, Equinox, Glaukos, Imprimis, Ivantis, J & J Vision, Ocuphire, MicroOptx, New World Medical, PolyActiva, Ripple Therapeutics, Santen, Sight Science, TearClear, ViaLase, Zeiss
Ownership Interest: BELKIN Laser, Equinox, Ivantis, Ocuphire, Sight Science, TearClear, ViaLase

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com